Visual field defects in pediatric patients on vigabatrin monotherapy

被引：0
作者：
Francisco J. Ascaso
María J. Lopez
José A. Mauri
José A. Cristobal
机构：
[1] University Clinic Hospital,Departments ofOphthalmology
[2] University Clinic Hospital,Departments ofChild Neurology and Neurology
[3] University Clinic Hospital,undefined
来源：
Documenta Ophthalmologica | 2003年 / 107卷
关键词：
antiepileptic drugs; childhood epilepsy; vigabatrin; visual field defects;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
Vigabatrin (GVG) is an effective antiepileptic drug used for treating partial seizures in adults and children. Over the last years, an increasing number of articles have been published reporting visual field defects (VFD) associated with GVG therapy in adults. To date, however, only an small number of pediatric patients have been reported. This paper is a retrospective review of clinical review to evaluate the prevalence and features of VFD in pediatric patients on GVG monotherapy. Methods: Fifteen children, on GVG therapy in the Department of Child Neurology, underwent visual field examination by static threshold automated perimetry using the Humphrey Field Analyzer Program 30-2. The age of these patients ranged from 6 to 18 years (12.4 ± 3.6 years), 10 of them being male and five female. Results: Three patients (20%) on GVG monotherapy showed VFD. These consisted in localised, bilateral, and relatively symmetrical, nasal field loss, with relative preservation of the temporal field within the central 30° area.
引用
收藏
页码：127 / 130
页数：3
相关论文
共 102 条
[1]  
Eke T(1997)Severe persistent visual field constriction associated with vigabatrin Br Med J 314 180-1
[2]  
Talbot JF(1997)Severe persistent visual field constriction associated with vigabatrin. Chronic refractory epilepsy may have role in causing these unusual lesions BrMed J 314 1693-4
[3]  
Lawden MC.(1997)Severe persistent visual field constriction associated with vigabatrin. Reaction might be dose dependent Br Med J 314 1693-8
[4]  
Wilson EA(1997)Severe persistent visual field constriction associated with vigabatrin. Patients taking vigabatrin should have regular visual field testing Br Med J 314 1694-9
[5]  
Brodie MJ.(1997)Severe persistent visual field constriction associated with vigabatrin. Four possible explanations exixt Br Med J 314 1694-22
[6]  
Wong ICK(1997)Severe persistent visual field constriction associated with vigabatrin. Asymptomatic as well as symptomatic defects occur with vigabatrin Br Med J 314 1693-94
[7]  
Mawer GE(1998)Vigabatrin-associated retinal cone system dysfunction. Electroretinogram and ophthalmologic findings Neurology 50 614-6
[8]  
Sanders JW.(1997)Vigabatrinassociated bilateral concentric visual field defects in four patients Epilepsia 38 179-505
[9]  
Blackwell N(1998)Electrophysiologic evaluation of a patient with peripheral visual field cotraction associated with vigabatrin Arch Ophthalmol 116 817-2
[10]  
Hayllar J(1997)Electroculography, ERGs, multifocal ERGs and VEPs in epileptic patients showing visual field disorders Electroencephalogr Clin Electrophysiol 103 96-9
12345678910